| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | Anacor Pharmaceuticals Inc | 1,067,892 | 57,079,000 | 31.25% | ||
| 2 | INTRALINKS HLDGS INC | 6,290,503 | 49,569,000 | 27.14% | ||
| 3 | EVERYDAY HEALTH INC | 4,107,522 | 23,002,000 | 12.59% | ||
| 4 | INOTEK PHARMACEUTICALS CORP | 2,627,790 | 19,446,000 | 10.65% | ||
| 5 | CARA THERAPEUTICS INC | 3,068,057 | 19,083,000 | 10.45% | ||
| 6 | RUBICON PROJ INC | 437,390 | 7,995,000 | 4.38% | ||
| 7 | REACHLOCAL INC | 2,570,395 | 4,601,000 | 2.52% | ||
| 8 | SENSEONICS HOLDINGS INC | 462,794 | 1,324,000 | 0.72% | ||
| 9 | Nephrogenex Inc | 1,052,966 | 495,000 | 0.27% | ||
| 10 | XTERA COMMUNICATIONS INC | 13,366 | 38,000 | 0.02% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001420506-16-000939, filed 2016.05.09).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
